Streetbeat News

Stock Prices

DXCM

Analysts have provided various ratings for DexCom (NASDAQ:DXCM) within the last quarter, with a total of 5 bullish, 3 somewhat bullish, and 2 indifferent ratings. The average price target given by these analysts is $140.2, which is higher than DexCom's current price of $97.05. However, this average has decreased by 2.91% from the previous average price target of $144.40.

Portfolio Pulse from Benzinga Insights

September 29, 2023 | 1:00 pm

AMH

Analysts have given American Homes 4 Rent (NYSE:AMH) mostly bullish ratings in the last quarter, with an average 12-month price target of $39.0, up 7.08% from the previous average of $36.42. In the last 3 months, 7 analysts have offered 12-month price targets for the company.

Portfolio Pulse from Benzinga Insights

September 29, 2023 | 1:00 pm

PODD

Over the past 3 months, 14 analysts have published their opinion on Insulet (NASDAQ:PODD) stock. The company has an average price target of $265.57, a 17.3% decrease from the previous average price target of $321.14. The ratings include 2 bullish, 5 somewhat bullish, and 7 indifferent.

Portfolio Pulse from Benzinga Insights

September 29, 2023 | 1:00 pm

ABBV

Over the past three months, four analysts have published their opinions on AbbVie (NYSE:ABBV) stock, with one being bullish and three somewhat bullish. The average 12-month price target for AbbVie is $174.0, with a high of $182.00 and a low of $167.00. This average price target has increased by 0.87% over the past month.

Portfolio Pulse from Benzinga Insights

September 29, 2023 | 1:00 pm

UBS

UBS Group AG's subsidiary Credit Suisse reported a significant increase in 6M FY23 revenue to CHF17.1 billion, up from CHF8.13 billion a year ago. However, the company expects a loss of $1.6 billion from reclassifying loans related to its non-core and legacy businesses. Additionally, Credit Suisse witnessed net asset outflows of CHF100.3 billion in the period. UBS shares are trading higher by 1.13% at $24.98 premarket.

Portfolio Pulse from Lekha Gupta

September 29, 2023 | 12:59 pm

USAC

Mizuho analyst Gabriel Moreen has downgraded USA Compression Partners (NYSE:USAC) from Neutral to Underperform and set a price target of $22.

Portfolio Pulse from Benzinga Newsdesk

September 29, 2023 | 12:58 pm

LGST

Semper Paratus Acquisition Corporation has regained compliance with certain Nasdaq listing requirements.

Portfolio Pulse from Benzinga Newsdesk

September 29, 2023 | 12:55 pm

GPCR

NVO

Structure Therapeutics Inc released results from the Phase 1b study of GSBR-1290, showing significant weight loss in overweight or obese individuals. The company also announced a private placement of 21.6 million shares and 2.4 million non-voting shares at $12.49 per share, raising $300 million. The funds are expected to extend the cash runway through 2026. GPCR shares are up 68.1% in premarket trading.

Portfolio Pulse from Vandana Singh

September 29, 2023 | 12:55 pm

TLRY

Tilray Brands, Inc. (NASDAQ:TLRY) has announced the launch of an expanded product lineup by its cannabis lifestyle brand, CANACA. The new 'Let 'Er Rip' Campaign introduces a curated collection of products designed to elevate intensity while offering flavorful and aromatic consumption experiences. The campaign highlights two product lines, including additional whole flower and Crumble Cones pre-rolls. Tilray’s shares traded 0.8511% higher at $2.37 per share during the pre-market session of Friday morning.

Portfolio Pulse from Jelena Martinovic

September 29, 2023 | 12:54 pm

ABT

POCT

VNQ

On CNBC's 'Halftime Report Final Trades', several financial experts named their final trades. Bryn Talkington picked Innovator U.S. Equity Power Buffer ETF October (POCT), Stephen Weiss chose U.S. 10 Year Treasury Note, Brenda Vingiello selected Abbott Laboratories (ABT), and Shannon Saccocia picked Vanguard Real Estate Index Fund (VNQ). Abbott Laboratories recently agreed to acquire Bigfoot Biomedical and its shares gained 2.7% to close at $98.12 on Thursday.

Portfolio Pulse from Priya Nigam

September 29, 2023 | 12:54 pm